This event is now closed, information is displayed here for information only.
It would not be possible to run the British Symposium on Diabetic Neuropathy without the much appreciated support from colleagues in the pharmaceutical and medical devices industry.
The following companies have supported the 2016 meeting.
The following sponsor has not been involved in the organisation, content or speaker selection.Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).